The Company requests a trading halt effective immediately allowing the Company to seek external advice on the data contained in the pending release of an announcement relating to an update on the Company’s NOXCOVID Clinical Program and Veyonda® drug candidate (“NOXCOVID Update”.
If I read this correctly, the company is going to release data from the NOXCOVID program, THEN seek external comment - presumably from experts in this field - while under a Trading Halt.
Ann: Trading Halt, page-4
-
- There are more pages in this discussion • 68 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.5¢ |
Change
0.010(9.52%) |
Mkt cap ! $33.60M | |||
| Open | High | Low | Value | Volume |
| 12.5¢ | 14.0¢ | 11.0¢ | $559.0K | 4.481M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 6612 | 11.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.0¢ | 99714 | 1 |
View Market Depth
| Last trade - 16.10pm 03/09/2024 (20 minute delay) ? |
| NOX (ASX) Chart |